Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-002962
Filing Date
2025-03-19
Accepted
2025-03-19 11:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27552
2 filename2.txt TEXT-EXTRACT 922
  Complete submission text file 0000000000-25-002962.txt   39657
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filed for) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: UPLOAD | File No.: 001-39398
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)